Study Stopped
lack of inclusion
"Guarantee Assessment in Skin Prevention Adapted to Real Life With a Connected Device After a Spinal Cord Injury."
GASPARD-SCI
1 other identifier
interventional
134
1 country
1
Brief Summary
The investigators propose to test an embedded device on the seat of the wheelchair of paraplegic or tetraplegic patients (Gaspard), allowing on the one hand the continuous measurement of the pressures of seat, on the other hand a retro-control connected to the cell phone of the participants to inform them on these variables of seat (bad positioning, prolonged supports etc...) This study will be carried out over a long period of time (1 year), in an ergonomic situation of integration in the daily life of the participants. The main objective of this randomized controlled study is to study the difference in the incidence of pressure sores according to the use or not of this device. A qualitative study of the experience and perceived benefit of its use and a medico-economic study are associated to judge the expected interest in making this type of embedded device more systematically integrated into the classic movement equipment (wheelchair and seat cushion) of people with a spinal cord injury
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
June 3, 2022
CompletedStudy Start
First participant enrolled
January 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 3, 2026
CompletedApril 20, 2026
April 1, 2026
3.1 years
May 19, 2022
April 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of patients per group for whom a pressure ulcer occurred.
1 year
Secondary Outcomes (6)
Incremental cost-utility ratio of a connected electronic seat pressure measurement device (GASPARD®) compared to traditional management (= without device)
1 year
Skin Risk Knowledge Questionnaire Revised-SMNAC (Skin Management Needs Assessment Checklist)
1 year
Cross-analysis and thematic analysis of the comments made during the focus groups, particularly with regard to the perception of one's ability to take charge of one's health and the connected dimension of the device.
1 year
Frequency of pelvic location of pressure ulcer (sacrum, ischium, trochanters). Frequency of pressure ulcer stages (1 to 4)
1 year
Number of pressure sores per patient
1 year
- +1 more secondary outcomes
Study Arms (2)
Experimental Group (GASPARD®)
EXPERIMENTALSpinal cord injured patient with the connected electronic seat pressure measurement device (GASPARD®), a traditional follow-up and having received therapeutic education at the end of the treatment
Control group:
NO INTERVENTIONSpinal cord injured patient with traditional follow-up with therapeutic education at discharge from initial care
Interventions
Spinal cord injured patient with the connected electronic seat pressure measurement device (GASPARD®), a traditional follow-up and having received therapeutic education at the end of the treatment
Eligibility Criteria
You may qualify if:
- Patients of both sexes with acquired spinal cord injury Traumatic or non-traumatic origin of the spinal cord injury
- Motor level \< C6
- Complete or incomplete injury (AIS A, B and C impairment scale)
- Primarily using a manual wheelchair (with or without electric propulsion assistance) as a means of mobility
- At least 18 years of age
- At any time after the occurrence of the spinal cord injury
- Patients discharged from the center, with a first post-injury rehabilitation completed
- Having participated in a specific therapeutic patient education on pressure ulcer prevention
- No aorto-iliac arterial disease that may promote pelvic ischemia (arterial Doppler \<6 months)
- Patient using a cushion approved by the HAS
- Patients with a smartphone
You may not qualify if:
- Congenital spinal cord injury
- Motor level of the lesion \> or = C6
- Incomplete motor lesion (AIS D and E)
- Patients who walk as their primary mode of ambulation
- Use of an electric wheelchair
- Minors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Le FORT Marc
Nantes, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MARC LE FORT
Nantes University Hospital
- PRINCIPAL INVESTIGATOR
GAELLE AUDAT
CRRF l'Arche
- PRINCIPAL INVESTIGATOR
RECH CELIA
Raymond Poincaré Hospital
- PRINCIPAL INVESTIGATOR
KERDRAON Jacques
CRRF Kerpape
- PRINCIPAL INVESTIGATOR
GELIS ANTHONY
Centre Mutualiste Neurologique Propora
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
June 3, 2022
Study Start
January 1, 2023
Primary Completion
February 3, 2026
Study Completion
February 3, 2026
Last Updated
April 20, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share